- Conditions
- Focus: Prevent Preterm Delivery, Incidental Short Cervix at Mid-trimester
- Interventions
- Arabin Pessary
- Drug
- Lead sponsor
- University of Illinois at Chicago
- Other
- Eligibility
- 18 Years to 49 Years · Female only
- Enrollment
- 57 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
Source: ClinicalTrials.gov public record
Updated Aug 4, 2020 · Synced May 21, 2026, 10:50 PM EDT